Menu
ABOUT
ABOUT
1
The main objective of the CorEuStem is to develop an efficient and effective consortium for harmonizing procedures, protocols and tools to provide efficient benchmarking, quality control and intensive training.
2
One of the major challenges for core facilities is to keep track, evaluate and implement cutting-edge technologies. Core facilities strive to standardize, evaluate, adopt and implement new technologies in the field of hPSCs, organoid biology and gene editing
3
In the past 12 years, experimental approaches used in biomedical research have been reshaped by the discovery of human induced pluripotent stem cells (iPSCs), the development of CRISPR/Cas9 gene editing technology and the possibility of generating in vitro organ-like structures called organoids.
Structure
Join the action
The COST Action CorEuStem welcomes research-active scientists working in the field. There are many ways to get involved.
News
The CorEuStem Training School 2024 – Advances in reprogramming & CRISPR/Cas9 will take place at the Centre for Genomic Regulation (CRG) in Barcelona, Spain, on 16th April 2024. The meeting will gather experts from the different core facilities in Europe, covering the latest advances in human stem cells and gene editing technologies. Confirmed speakers are: Dr. Ana Belén Álvarez-Palomo (Banc de Sang i...
CorEuStem is proud to announce the official launch of the European Core Facilities Database on our webpage! Please take a look at it here. CorEuStem COST Action led the initiative to compile all Stem Cell and Gene Editing Core Facilities running in Europe, as well as the main services provided by each one of them...
European University Initiative (EUTOPIA) week took place from 4 to 6 December 2023 at the Technische Universität Dresden (TUD), Dresden, Germany. Among the different aspects covered, during the EUTOPIA Research Infrastructures Cooperation Symposium, Interinstitutional/European Research Infrastrutures Networks were presented and discussed, including an hybrid talk given by CorEuStem members, Dr. Inês Figueira (NOVA University Lisbon) and...
Next CorEuStem webinar will be held November 9th, 2023, 11.00 – 12:00 (CET). Please register here to attend. Speaker: Dr. Leszek LisowskiChildren’s Medical Research Institute (CMRI)The University of Sydney, Australia Dr. Leszek Lisowski is a world vectorology expert with over 15 years of experience in developing and manufacturing viral vectors for human gene therapy. Currently,...
Please join us for the next webinar on “Preclinical testing of CRISPR therapeutics for inherited diseases”. Date: October 6th , 14.00h -15.00h (Berlin time) Speaker: Dr. rer. nat. Lukas Cyganek University Medical Center Göttingen, Germany Please register to attend at: https://forms.gle/zTPgawWQb9ryAdWC8 Participation by Zoom: To ensure that the meeting is accessible for all CorEuStem members. If you would...
Last weekend, on 9-10 September, it took place the first edition of CorEuStem hands-on iPSC training school at Erasmus Medical Center, in Rotterdam, The Netherlands. The course covered two days of talks and laboratory practice using human iPSC. Students from seven different countries learned how to thaw, split and cryopreserve iPSC, as well as manually...
COST (European Cooperation in Science and Technology) is a funding organisation for research and innovation networks. Our Actions help connect research initiatives across Europe and beyond and enable researchers and innovators to grow their ideas in any science and technology field by sharing them with their peers. COST Actions are bottom-up networks with a duration of four years that boost research, innovation and careers.
The COST Action CorEuStem will be comprised of European core facilities that are experts in stem cell biology, differentiation, organoids and gene editing technologies with the aim of developing an efficient and effective consortium for harmonizing procedures and protocols across Europe and beyond.
MoU • Memorandum of Understanding
CSO Approval date: 25 May 2021
Action start date: 21 October 2021
Action end date: 20 October 2025
